ECPI Global Commodity GD

The ECPI Asian Infrastructure Index provides exposure to the 30 highest ESG-rated companies that are active in the Asian infrastructure industry.

Index Guides, Benchmark statement, and other reports are available under the Data tab.

The iSTOXX L&G Multifactor index is designed to provide exposure to regional Value, Momentum, Low Volatility and Quality risk-premia factors, where style factor scores are provided by Legal and General Investment Management (LGIM). The indices track the STOXX World regional indices, while ensuring tradability, diversification, and liquidity.

Index Guides, Benchmark statement, and other reports are available under the Data tab.

The ISS STOXX World AC ESG Climbers Index selects securities from the STOXX World AC universe that consistently improve their ESG performance, with standardized ESG exclusion screens applied for ISS ESG Norms Based Screening assessment, a set of definitions for Controversial Weapons, Tobacco, Thermal Coal, Unconventional Oil & Gas, Civilian Firearms and Military Equipment. The objective is to select such companies that are on trajectory to become ESG leaders in the future, based on whether their ISS ESG Corporate Ratings Overall Numeric Scores have improved at least 5 times if they are assigned to Developed Markets and at least 3 times of improvement if they are assigned to Emerging Markets in the past 5 years, and are required to improve at least 3 times if they are assigned to Developed Markets and 2 times if they are assigned to Emerging Markets in order to remain as constituents. The methodology also removes securities whose issuers are poor ESG performers, where their ISS ESG Corporate Ratings Overall Numeric Score is lower than 1.75. Securities whose issuers do not receive ESG Rating as of the effective review are also excluded.

Index Guides, Benchmark statement, and other reports are available under the Data tab.

The ECPI Global ESG Health Care Innovation Index is an equally weighted index, of 100 components, designed to offer investors exposure to companies active in the fields of health care, health care technology, new pharmaceutical solutions, biotechnology, and life expectancies and senior population care needs.

Index Guides, Benchmark statement, and other reports are available under the Data tab.